• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.50% Nasdaq Up0.51%

    Ampio Pharmaceuticals, Inc. (AMPE)

    -NYSE MKT
    2.56 Up 0.05(1.99%) 2:13PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 21   21   21   21  
    Cost of Revenue -   -   -   -  
    Gross Profit 21   21   21   21  
    Operating Expenses
    Research Development4,660  7,217  6,267  5,611  
    Selling General and Administrative2,961  2,963  3,252  3,351  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (7,600) (10,158) (9,497) (8,940)
    Income from Continuing Operations
    Total Other Income/Expenses Net8  6  6  8  
    Earnings Before Interest And Taxes(7,591)(10,153)(9,492)(8,933)
    Interest Expense -   -   -   -  
    Income Before Tax(7,591)(10,153)(9,492)(8,933)
    Income Tax Expense -   -   -   -  
    Minority Interest308  241  212  241  
    Net Income From Continuing Ops(7,284)(9,912)(9,280)(8,692)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (7,284) (9,912) (9,280) (8,692)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (7,284) (9,912) (9,280) (8,692)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.